511509 — Vivo Bio Tech Balance Sheet
0.000.00%
- IN₹781.01m
- IN₹1.31bn
- IN₹466.73m
- 80
- 79
- 55
- 86
Annual balance sheet for Vivo Bio Tech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | C2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | Interim Report | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 11.7 | 17.1 | 13.7 | 13.9 | 12.8 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 120 | 136 | 192 | 360 | 321 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 271 | 260 | 318 | 472 | 419 |
| Net Property, Plant And Equipment | 410 | 824 | 800 | 815 | 772 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 795 | 1,225 | 1,230 | 1,371 | 1,432 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 218 | 244 | 250 | 379 | 278 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 370 | 765 | 712 | 827 | 653 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 425 | 459 | 519 | 544 | 779 |
| Total Liabilities & Shareholders' Equity | 795 | 1,225 | 1,230 | 1,371 | 1,432 |
| Total Common Shares Outstanding |